查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1559458

全球骨移植與人工骨市場：洞察、競爭格局、市場預測：2030年

Bone Grafts and Substitutes - Market Insights, Competitive Landscape and Market Forecast - 2030
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

2023年骨移植和人造骨的市場規模為30.2億美元。預計到2030年，該市場將達到 42.9億美元，2024年至2030年的預測期間年複合成長率為 6.06%。骨移植和人造骨市場預計將受到交通事故等創傷發生率上升以及骨關節炎和類風濕性關節炎等退化性疾病的推動，成為2024年至2030年預測期內推動市場的關鍵因素，市場正顯著成長。

根據世界衛生組織 (WHO) 道路交通傷害情況說明書 (2023) 的資料，道路交通傷害是 5 至 29 歲兒童和年輕人的第一大死因。情況說明書也指出，每年約有 2,000萬至近 5,000萬人因交通事故而遭受非致命傷害並致殘。此類事故的主要原因是骨折和脫臼，這對患者的生活品質有巨大影響。因此，骨移植和人造骨用於修復和再生因骨折或脫位而受損的骨組織。透過促進骨骼生長和減少恢復時間，它可以加速癒合、恢復功能並提高患者的生活品質。

根據世界衛生組織 (WHO) (2023) 的資料，全球平均有 3.44億人患有骨關節炎。其中，73%的骨關節炎患者年齡在55歲以上，其中60%是女性。此外，根據同一來源，有 1300萬人患有類風濕性關節炎。骨移植和替代品可以透過修復受損的關節和支持骨再生來幫助治療骨關節炎和類風濕性關節炎。骨移植通常在手術中用於緩解症狀、改善關節功能、幫助復原和改善生活品質。

然而，與骨移植和人造骨相關的併發症，如感染、傷口引流、血腫、再次手術、長時間疼痛、感覺喪失和疤痕疙瘩可能會抑制骨移植和人造骨市場的成長。

本報告調查了全球骨移植和人造骨市場，按原材料類型、產品類型、應用、最終用戶、地區的趨勢，以及進入市場的公司提供了市場概況。

目錄

第1章 骨移植與人工骨市場報告介紹

第2章 移植與人工骨市場執行摘要

第3章 競爭態勢

第4章 監理分析

  • 美國
  • 歐洲
  • 日本
  • 中國

第5章 植骨及人工骨市場主要因素分析

  • 骨移植與人工骨市場驅動因素
  • 限制骨移植和人造骨市場的因素和挑戰
  • 骨移植和人造骨的市場機會

第6章 骨移植與人工骨市場的波特五力分析

第7章 骨移植和人工骨的市場評估

  • 依原料類型
    • 設備
    • 試劑/試劑盒
  • 依產品類型
    • 同種異體移植物
    • 異種移植
    • 其他
  • 依用途
    • 顱顏面
    • 牙科
    • 關節重建
    • 脊柱
  • 依最終用戶
    • 醫院/診所
    • 專科診所
  • 地區
    • 北美
    • 歐洲
    • 亞太地區
    • 其他領域

第8章 骨移植及人工骨市場公司及產品概況

  • Zimmer Biomet
  • Johnson & Johnson Services, Inc
  • Smith & Nephew
  • Stryker
  • Dentsply Sirona Inc
  • NuVasive Inc
  • Baxter
  • AlloSource
  • Orthofix Medical Inc
  • Musckuloskeletal Transplant Foundation
  • Bioventus
  • Exactech Inc
  • B. Braun Melsungen AG
  • SeaSpine
  • Medtronic
  • Institut Straumann AG
  • SOUTHERN IMPLANTS
  • MedBone Biomaterials
  • BioHorizons
  • NORAKER

第9章 KOL觀點

第10章 專案方法

第11章 關於 DelveInsight

第12章 免責聲明與聯絡我們

Product Code: DIMDCL0085

Bone Grafts and Substitutes Market by Source Type (Natural, Synthetic, and Others), Product Type (Allografts [Demineralized Bone Matrix Bone Morphogenetic Protein, and Cell-Based Matrices], Xenografts, and Others), Application (Craniomaxillofacial, Dental, Joint Reconstruction, Spine, Others), End-User (Hospitals, Specialty Clinics, and Others), Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a substantial CAGR forecast till 2030 owing to the rising number of trauma cases and widespread occurrence of bone-related disorders across the globe

The bone grafts and substitutes market was valued at USD 3.02 billion in 2023, growing at a CAGR of 6.06% during the forecast period from 2024 to 2030 to reach USD 4.29 billion by 2030. The bone grafts and substitutes market is experiencing significant growth, owing to the rising incidence of trauma cases that are often a result of road traffic accidents, widespread instances of degenerative conditions like osteoarthritis and rheumatoid arthritis, among others that are acting as key factors driving the bone grafts and substitutes market during the forecast period from 2024 to 2030.

Bone Grafts and Substitutes Market Dynamics:

As per data from the World Health Organization factsheet (2023) on road traffic injuries, road traffic injuries are the leading cause of fatality in children and young adults in the age group of 5-29 years. The same factsheet further stated that near about 20-50 million people suffer from non-fatal injuries in road accidents resulting in a disability as a result of their injury each year. These incidents majorly result in bone fractures and dislocations that can drastically affect the quality of life of patients. Hence, bone grafts and substitutes are used to repair and regenerate bone tissue damaged by fractures and dislocations. They help enhance healing, restore function, and improve the quality of life for patients by promoting bone growth and reducing recovery times.

According to the World Health Organization (2023), 344 million individuals are affected by osteoarthritis globally on average. Amongst this population, 73% of people living with osteoarthritis are older than 55 years, and 60% are female. Moreover, as per the same source, 13 million people are living with rheumatoid arthritis. Bone grafts and substitutes assist in treating osteoarthritis and rheumatoid arthritis by repairing damaged joints and supporting bone regeneration. They alleviate symptoms, improve joint function, and are often used in surgical procedures to aid recovery and to enhance quality of life.

According to the World Health Organization (2024) in 2021, 15.4 million people were living with spinal cord injuries globally. Most cases of spinal cord injury result from trauma, including falls, or acts of violence, and are therefore preventable. Bone grafts and substitutes play a crucial role in treating spinal cord injuries by promoting spinal stability and aiding in the repair of damaged vertebrae. They help in facilitating the fusion of spinal segments, which can improve outcomes and prevent further injury.

Hence, the interplay of all the above mentioned factors are expected to drive the market for bone grafts and substitutes market during the given forecast period from 2024 to 2030.

However, complications associated with bone grafts and substitutes such as infection, wound drainage, hematomas, reoperation, prolonged pain, sensory loss, and keloids may restrain the growth of the bone grafts and substitutes market.

Bone Grafts and Substitutes Market Segment Analysis:

Bone Grafts and Substitutes Market by Source Type (Natural, Synthetic, and Others), Product Type (Allografts [Demineralized Bone Matrix Bone Morphogenetic Protein, and Cell-Based Matrices], Xenografts, and Others), Application (Craniomaxillofacial, Dental, Joint Reconstruction, Spine, Others), End-User (Hospitals, Specialty Clinics, and Others), Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the application segment of the bone grafts and substitutes market, the craniomaxillofacial category is predicted to account for the largest market revenue share in 2023. This is primarily due to growing number of surgeries involving craniofacial reconstruction, trauma, and corrective procedures. Advances in technology, such as 3D printing have enhanced the effectiveness of these device.

Craniomaxillofacial features a range of advanced materials designed to address complex craniofacial defects and injuries. These materials often include biocompatible polymers, ceramics, and composite materials that promote bone regeneration and integration with surrounding tissues. They are used in various applications such as repairing skull fractures, reconstructing facial deformities, and treating congenital anomalies.

Rising product developmental activities of this category are also likely to drive the market of these. For example in July 2021, Lucid Implants became the first Indian company to produce Polyether ether ketone (PEEK) based customized implants keeping patient's unique facial anatomy in mind with advanced 3D printing technologies and virtual surgical planning.

Therefore, due to the aforementioned factors, the craniomaxillofacial category is likely to witness considerable growth, eventually contributing to growth of overall bone grafts and substitutes market during the forecast period from 2024 to 2030.

North America is expected to dominate the overall Bone Grafts and Substitutes market:

Among all the regions, North America is expected to amass the largest share of the Bone Grafts and Substitutes market. This can be ascribed to the high instances of traumatic brain injuries and vertebral compression fractures, the increasing need for effective bone regeneration and stabilization, ongoing innovations in biomaterials, and presence of well established & advance healthcare infrastructure. Combined these factors, are expected to drive the bone grafts and substitutes market expansion from 2024 to 2030.

According to data provided by the Centre for Disease Control and Prevention (2024), in 2021, there were more than 586 traumatic brain injury-related hospitalizations per day in the US. Traumatic brain injuries, caused by head trauma from accidents, falls, or sports injuries, require prompt and accurate diagnosis to assess the extent of brain damage and guide treatment decisions. Bone grafts and substitutes are used in the treatment of traumatic brain injuries to promote healing and support bone regeneration, particularly in cases where skull fractures or damage occur. Thus, they aid in stabilizing the injured area and facilitating recovery by providing a scaffold for new bone growth.

According to the National Institute of Health (2023), it stated that vertebral compression fractures VCFs are the most frequently reported type of fragility fracture. In the US, approximately 1 to 1.5 million VCFs occur each year. Studies suggest that about 25% of women aged 50 and older have at least one VCF. Additionally, between 40% and 50% of individuals over the age of 80 are estimated to have experienced a VCF, either as an acute event or discovered incidentally during the evaluation of other health issues. Bone grafts and substitutes are commonly used in the treatment of vertebral compression fractures to promote healing and stabilize the affected vertebrae. They can help restore vertebral height and provide structural support, improving patient outcomes and reducing pain.

Moreover, the product developmental activities by the regulatory bodies in the region also push forward the revenue shares of bone graft and substitute market. For example in March 2024, Ventris Medical received the US Food and Drug Administration (FDA) clearance for its new bone graft putty, Amplify. This innovative synthetic biomaterial is designed to enhance cell proliferation and promote bone formation, representing a significant advancement in bone graft technology.

Thus, all the factors mentioned above promote a conducive growth environment for the bone grafts and substitutes market during the forecast period from 2024 to 2030.

Bone Grafts and Substitutes Market key players:

Some of the key market players operating in the Bone Grafts and Substitutes market include Zimmer Biomet, Johnson & Johnson Services, Inc, Smith & Nephew, Stryker, Nuvasive Inc, Baxter, AlloSource, Orthofix Medical Inc., Musckuloskeletal Transplant Foundation, Bioventus, Exactech Inc, B. Braun Melsungen AG, SeaSpine, Medtronic, Dentsply Sirona Inc. Institut Straumann AG, SOUTHERN IMPLANTS, MedBone Biomaterials, BioHorizons, NORAKER , and others.

Recent Developmental Activities in the Bone Grafts and Substitutes Market:

  • In March 2024, SurGenTec, a leading innovator in orthopedic and spine technologies, announced the successful implantation of its groundbreaking OsteoFlo HydroPutty Synthetic Bone Graft. The company also received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for this novel product.
  • In May 2023, the Food and Drug Administration (FDA) has approved Cerament G for use as a bone void filler in skeletally mature patients. It is intended to be used alongside systemic antibiotic therapy and surgical debridement as part of the treatment for osteomyelitis.
  • In May 2021, Prosidyan received the CE mark certifications for their fibergaft bone graft substitutes intended to be used in spinal fusion procedures.

Key Takeaways from the Bone Grafts and Substitutes Market Report Study

  • Market size analysis for current bone grafts and substitutes market size (2023), and market forecast for 6 years (2024 to 2030)
  • Top key product/services developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
  • Key companies dominating the bone grafts and substitutes market
  • Various opportunities available for the other competitors in the bone grafts and substitutes market space
  • What are the top-performing segments in 2023? How these segments will perform in 2030?
  • Which are the top-performing regions and countries in the current bone grafts and substitutes market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for bone grafts and substitutes market growth in the coming future?

Target audience who can be benefited from this Bone Grafts and Substitutes Market Report Study

  • Bone grafts and substitutes providers
  • Research organizations and consulting companies
  • Bone grafts and substitutes related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and traders dealing in bone grafts and substitutes
  • Various end-users who want to know more about the bone grafts and substitutes market and the latest developments in the bone grafts and substitutes market

Frequently Asked Questions for the Bone Grafts and Substitutes Market:

1. What is bone grafts and substitutes?

Bone grafts are implantable materials that are intended to promote bone healing, osseous reconstruction, and bone formation, due to their osteoinductive, osteoconductive, and osteogenic properties. Bone grafting is a surgical procedure for replacing a missing or defective bone with materials (bone graft) from a patient's body, cadavers, animals, or a different person. Bone grafts are also employed in filling bony voids in case of the absence of bones as well as providing structural stability.

2. What is the market for bone grafts and substitutes?

The bone grafts and substitutes market was valued at USD 3.02 billion in 2023, growing at a CAGR of 6.06% during the forecast period from 2024 to 2030 to reach USD 4.29 billion by 2030.

3. What are the drivers for the bone grafts and substitutes market?

The bone grafts and substitutes market is experiencing significant growth, owing to the rising incidence of trauma cases that are often a result of road traffic accidents, widespread instances of degenerative conditions like osteoarthritis and rheumatoid arthritis, and among others are acting as key factors to drive bone grafts and substitutes market during the forecast period from 2024 to 2030.

4. Who are the key players operating in the bone grafts and substitutes market?

Some of the key market players operating in the Bone Grafts and Substitutes market include Zimmer Biomet, Johnson & Johnson Services, Inc, Smith & Nephew, Stryker, Nuvasive Inc, Baxter, AlloSource, Orthofix Medical Inc., Musckuloskeletal Transplant Foundation, Bioventus, Exactech Inc, B. Braun Melsungen AG, SeaSpine, Medtronic, Dentsply Sirona Inc. Institut Straumann AG, SOUTHERN IMPLANTS, MedBone Biomaterials, BioHorizons, NORAKER, and others.

5. Which region has the highest share in the bone grafts and substitutes market?

Among all the regions, North America is estimated to hold a significant revenue share in the Bone Grafts and Substitutes market. This can be ascribed to the high instances of traumatic brain injuries and vertebral compression fractures, the increasing need for effective bone regeneration and stabilization, and ongoing innovations in biomaterials, and the presence of well-established & advance healthcare infrastructure. Combined these factors, are expected to drive the bone grafts and substitutes market expansion from 2024 to 2030.

Table of Contents

1. Bone Grafts and Substitutes Market Report Introduction

  • 1.1. Scope of the Study
  • 1.2. Market Segmentation
  • 1.3. Market Assumption

2. Bone Grafts and Substitutes Market Executive Summary

  • 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

  • 4.1. The United States
  • 4.2. Europe
  • 4.3. Japan
  • 4.4. China

5. Bone Grafts and Substitutes Market Key Factors Analysis

  • 5.1. Bone Grafts and Substitutes Market Drivers
    • 5.1.1. Rising number of trauma cases
    • 5.1.2. Widespread occurrence of bone-related disorders
    • 5.1.3. Growing geriatric population
  • 5.2. Bone Grafts and Substitutes Market Restraints and Challenges
    • 5.2.1. Complications associated with bone grafts and substitutes such as infection, wound drainage, hematomas, reoperation, prolonged pain, sensory loss, and keloids
  • 5.3. Bone Grafts and Substitutes Market Opportunities
    • 5.3.1. Development of Porous Synthetic Substitutes
    • 5.3.2. The incorporation of robotic systems and artificial intelligence in bone graft procedure

6. Bone Grafts and Substitutes Market Porter's Five Forces Analysis

  • 6.1. Bargaining Power of Suppliers
  • 6.2. Bargaining Power of Consumers
  • 6.3. Threat of New Entrants
  • 6.4. Threat of Substitutes
  • 6.5. Competitive Rivalry

7. Bone Grafts and Substitutes Market Assessment

  • 7.1. By Source Type
    • 7.1.1. Instruments
    • 7.1.2. Reagents & Kits
  • 7.2. By Product Type
    • 7.2.1. Allografts
      • 7.2.1.1. DBM
      • 7.2.1.2. BMP
      • 7.2.1.3. Cell-Based Matrices
    • 7.2.2. Xenografts
    • 7.2.3. Others
  • 7.3. By Application
    • 7.3.1. Craniomaxillofacial
    • 7.3.2. Dental
    • 7.3.3. Joint Reconstruction
    • 7.3.4. Spine
    • 7.3.5. Others
  • 7.4. By End-User
    • 7.4.1. Hospitals & Clinics
    • 7.4.2. Specialty Clinics
    • 7.4.3. Others
  • 7.5. By Geography
    • 7.5.1. North America
      • 7.5.1.1. United States Bone Grafts and Substitutes Market Size in USD million (2021-2030)
      • 7.5.1.2. Canada Bone Grafts and Substitutes Market Size in USD million (2021-2030)
      • 7.5.1.3. Mexico Bone Grafts and Substitutes Market Size in USD million (2021-2030)
    • 7.5.2. Europe
      • 7.5.2.1. France Bone Grafts and Substitutes Market Size in USD million (2021-2030)
      • 7.5.2.2. Germany Bone Grafts and Substitutes Market Size in USD million (2021-2030)
      • 7.5.2.3. United Kingdom Bone Grafts and Substitutes Market Size in USD million (2021-2030)
      • 7.5.2.4. Italy Bone Grafts and Substitutes market size in USD million (2021-2030)
      • 7.5.2.5. Spain Bone Grafts and Substitutes Market Size in USD million (2021-2030)
      • 7.5.2.6. Rest of Europe Bone Grafts and Substitutes Market Size in USD million (2021-2030)
    • 7.5.3. Asia-Pacific
      • 7.5.3.1. China Bone Grafts and Substitutes Market Size in USD million (2021-2030)
      • 7.5.3.2. Japan Bone Grafts and Substitutes Market Size in USD million (2021-2030)
      • 7.5.3.3. India Bone Grafts and Substitutes Market Size in USD million (2021-2030)
      • 7.5.3.4. Australia Bone Grafts and Substitutes Market Size in USD million (2021-2030)
      • 7.5.3.5. South Korea Bone Grafts and Substitutes Market Size in USD million (2021-2030)
      • 7.5.3.6. Rest of Asia-Pacific Bone Grafts and Substitutes Market Size in USD million (2021-2030)
    • 7.5.4. Rest of the World (RoW)
      • 7.5.4.1. Middle East Bone Grafts and Substitutes Market Size in USD million (2021-2030)
      • 7.5.4.2. Africa Bone Grafts and Substitutes Market Size in USD million (2021-2030)
      • 7.5.4.3. South America Bone Grafts and Substitutes Market Size in USD million (2021-2030)

8. Bone Grafts and Substitutes Market Company and Product Profiles

  • 8.1. Zimmer Biomet
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. Johnson & Johnson Services, Inc
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. Smith & Nephew
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. Stryker
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. Dentsply Sirona Inc
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. NuVasive Inc
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. Baxter
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. AlloSource
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. Orthofix Medical Inc
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. Musckuloskeletal Transplant Foundation
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy
  • 8.11. Bioventus
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4. Product Listing
    • 8.11.5. Entropy
  • 8.12. Exactech Inc
    • 8.12.1. Company Overview
    • 8.12.2. Company Snapshot
    • 8.12.3. Financial Overview
    • 8.12.4. Product Listing
    • 8.12.5. Entropy
  • 8.13. B. Braun Melsungen AG
    • 8.13.1. Company Overview
    • 8.13.2. Company Snapshot
    • 8.13.3. Financial Overview
    • 8.13.4. Product Listing
    • 8.13.5. Entropy
  • 8.14. SeaSpine
    • 8.14.1. Company Overview
    • 8.14.2. Company Snapshot
    • 8.14.3. Financial Overview
    • 8.14.4. Product Listing
    • 8.14.5. Entropy
  • 8.15. Medtronic
    • 8.15.1. Company Overview
    • 8.15.2. Company Snapshot
    • 8.15.3. Financial Overview
    • 8.15.4. Product Listing
    • 8.15.5. Entropy
  • 8.16. Institut Straumann AG
    • 8.16.1. Company Overview
    • 8.16.2. Company Snapshot
    • 8.16.3. Financial Overview
    • 8.16.4. Product Listing
    • 8.16.5. Entropy
  • 8.17. SOUTHERN IMPLANTS
    • 8.17.1. Company Overview
    • 8.17.2. Company Snapshot
    • 8.17.3. Financial Overview
    • 8.17.4. Product Listing
    • 8.17.5. Entropy
  • 8.18. MedBone Biomaterials
    • 8.18.1. Company Overview
    • 8.18.2. Company Snapshot
    • 8.18.3. Financial Overview
    • 8.18.4. Product Listing
    • 8.18.5. Entropy
  • 8.19. BioHorizons
    • 8.19.1. Company Overview
    • 8.19.2. Company Snapshot
    • 8.19.3. Financial Overview
    • 8.19.4. Product Listing
    • 8.19.5. Entropy
  • 8.20. NORAKER
    • 8.20.1. Company Overview
    • 8.20.2. Company Snapshot
    • 8.20.3. Financial Overview
    • 8.20.4. Product Listing
    • 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Bone Grafts and Substitutes Market in Global (2021-2030)
  • Table 3: Bone Grafts and Substitutes Market in Global by Source Type (2021-2030)
  • Table 4: Bone Grafts and Substitutes Market in Global by Product Type (2021-2030)
  • Table 5: Bone Grafts and Substitutes Market in Global by Application (2021-2030)
  • Table 6: Bone Grafts and Substitutes Market in Global by End-User (2021-2030)
  • Table 7: Bone Grafts and Substitutes Market in Global by Geography (2021-2030)
  • Table 8: Bone Grafts and Substitutes Market in North America (2021-2030)
  • Table 9: Bone Grafts and Substitutes Market in the United States (2021-2030)
  • Table 10: Bone Grafts and Substitutes Market in Canada (2021-2030)
  • Table 11: Bone Grafts and Substitutes Market in Mexico (2021-2030)
  • Table 12: Bone Grafts and Substitutes Market in Europe (2021-2030)
  • Table 13: Bone Grafts and Substitutes Market in France (2021-2030)
  • Table 14: Bone Grafts and Substitutes Market in Germany (2021-2030)
  • Table 15: Bone Grafts and Substitutes Market in United Kingdom (2021-2030)
  • Table 16: Bone Grafts and Substitutes Market in Italy (2021-2030)
  • Table 17: Bone Grafts and Substitutes Market in Spain (2021-2030)
  • Table 18: Bone Grafts and Substitutes Market in the Rest of Europe (2021-2030)
  • Table 19: Bone Grafts and Substitutes Market in Asia-Pacific (2021-2030)
  • Table 20: Bone Grafts and Substitutes Market in China (2021-2030)
  • Table 21: Bone Grafts and Substitutes Market in Japan (2021-2030)
  • Table 22: Bone Grafts and Substitutes Market in India (2021-2030)
  • Table 23: Bone Grafts and Substitutes Market in Australia (2021-2030)
  • Table 24: Bone Grafts and Substitutes Market in South Korea (2021-2030)
  • Table 25: Bone Grafts and Substitutes Market in Rest of Asia-Pacific (2021-2030)
  • Table 26: Bone Grafts and Substitutes Market in the Rest of the World (2021-2030)
  • Table 27: Bone Grafts and Substitutes Market in the Middle East (2021-2030)
  • Table 28: Bone Grafts and Substitutes Market in Africa (2021-2030)
  • Table 29: Bone Grafts and Substitutes Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Bone Grafts and Substitutes Market in Global (2021-2030)
  • Figure 3: Bone Grafts and Substitutes Market in Global by Source Type (2021-2030)
  • Figure 4: Bone Grafts and Substitutes Market in Global by Product Type (2021-2030)
  • Figure 5: Bone Grafts and Substitutes Market in Global by Application (2021-2030)
  • Figure 6: Bone Grafts and Substitutes Market in Global by End-User (2021-2030)
  • Figure 7: Bone Grafts and Substitutes Market in Global by Geography (2021-2030)
  • Figure 8: Bone Grafts and Substitutes Market in North America (2021-2030)
  • Figure 9: Bone Grafts and Substitutes Market in the United States (2021-2030)
  • Figure 10: Bone Grafts and Substitutes Market in Canada (2021-2030)
  • Figure 11: Bone Grafts and Substitutes Market in Mexico (2021-2030)
  • Figure 12: Bone Grafts and Substitutes Market in Europe (2021-2030)
  • Figure 13: Bone Grafts and Substitutes Market in France (2021-2030)
  • Figure 14: Bone Grafts and Substitutes Market in Germany (2021-2030)
  • Figure 15: Bone Grafts and Substitutes Market in United Kingdom (2021-2030)
  • Figure 16: Bone Grafts and Substitutes Market in Italy (2021-2030)
  • Figure 17: Bone Grafts and Substitutes Market in Spain (2021-2030)
  • Figure 18: Bone Grafts and Substitutes Market in the Rest of Europe (2021-2030)
  • Figure 19: Bone Grafts and Substitutes Market in Asia-Pacific (2021-2030)
  • Figure 20: Bone Grafts and Substitutes Market in China (2021-2030)
  • Figure 21: Bone Grafts and Substitutes Market in Japan (2021-2030)
  • Figure 22: Bone Grafts and Substitutes Market in India (2021-2030)
  • Figure 23: Bone Grafts and Substitutes Market in Australia (2021-2030)
  • Figure 24: Bone Grafts and Substitutes Market in South Korea (2021-2030)
  • Figure 25: Bone Grafts and Substitutes Market in Rest of Asia-Pacific (2021-2030)
  • Figure 26: Bone Grafts and Substitutes Market in the Rest of the World (2021-2030)
  • Figure 27: Bone Grafts and Substitutes Market in the Middle East (2021-2030)
  • Figure 28: Bone Grafts and Substitutes Market in Africa (2021-2030)
  • Figure 29: Bone Grafts and Substitutes Market in South America (2021-2030)
  • Figure 30: Market Drivers
  • Figure 31: Market Barriers
  • Figure 32: Marker Opportunities
  • Figure 33: PORTER'S Five Force Analysis